Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls
- PMID: 30287823
- PMCID: PMC6172276
- DOI: 10.1038/s41467-018-06581-8
Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls
Abstract
Pathogenic variants in highly penetrant genes are useful for the diagnosis, therapy, and surveillance for hereditary breast cancer. Large-scale studies are needed to inform future testing and variant classification processes in Japanese. We performed a case-control association study for variants in coding regions of 11 hereditary breast cancer genes in 7051 unselected breast cancer patients and 11,241 female controls of Japanese ancestry. Here, we identify 244 germline pathogenic variants. Pathogenic variants are found in 5.7% of patients, ranging from 15% in women diagnosed <40 years to 3.2% in patients ≥80 years, with BRCA1/2, explaining two-thirds of pathogenic variants identified at all ages. BRCA1/2, PALB2, and TP53 are significant causative genes. Patients with pathogenic variants in BRCA1/2 or PTEN have significantly younger age at diagnosis. In conclusion, BRCA1/2, PALB2, and TP53 are the major hereditary breast cancer genes, irrespective of age at diagnosis, in Japanese women.
Conflict of interest statement
The authors declare no competing interests.
Figures


Similar articles
-
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.JAMA Oncol. 2017 Sep 1;3(9):1190-1196. doi: 10.1001/jamaoncol.2017.0424. JAMA Oncol. 2017. PMID: 28418444 Free PMC article.
-
The relationship between BRCA-associated breast cancer and age factors: an analysis of the Japanese HBOC consortium database.J Hum Genet. 2021 Mar;66(3):307-314. doi: 10.1038/s10038-020-00849-y. Epub 2020 Oct 12. J Hum Genet. 2021. PMID: 33046835 Free PMC article.
-
Evaluation of pathogenetic mutations in breast cancer predisposition genes in population-based studies conducted among Chinese women.Breast Cancer Res Treat. 2020 Jun;181(2):465-473. doi: 10.1007/s10549-020-05643-0. Epub 2020 Apr 21. Breast Cancer Res Treat. 2020. PMID: 32318955 Free PMC article.
-
Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis.Breast Cancer Res Treat. 2020 Jul;182(2):465-476. doi: 10.1007/s10549-020-05710-6. Epub 2020 Jun 2. Breast Cancer Res Treat. 2020. PMID: 32488392
-
Current review of TP53 pathogenic germline variants in breast cancer patients outside Li-Fraumeni syndrome.Hum Mutat. 2018 Dec;39(12):1764-1773. doi: 10.1002/humu.23656. Epub 2018 Oct 3. Hum Mutat. 2018. PMID: 30240537 Review.
Cited by
-
Assessing the efficacy of target adaptive sampling long-read sequencing through hereditary cancer patient genomes.NPJ Genom Med. 2024 Feb 17;9(1):11. doi: 10.1038/s41525-024-00394-z. NPJ Genom Med. 2024. PMID: 38368425 Free PMC article.
-
Germline rare variants in HER2-positive breast cancer predisposition: a systematic review and meta-analysis.Front Oncol. 2024 Jun 24;14:1395970. doi: 10.3389/fonc.2024.1395970. eCollection 2024. Front Oncol. 2024. PMID: 38978731 Free PMC article.
-
Impact of lower co-payments on risk-reducing salpingo-oophorectomy and BRCA testing in Japan.Arch Public Health. 2023 Feb 27;81(1):32. doi: 10.1186/s13690-023-01048-9. Arch Public Health. 2023. PMID: 36849964 Free PMC article.
-
Genetic Characterization of Hereditary Cancer Syndromes Based on Targeted Next-Generation Sequencing.Mol Syndromol. 2022 Feb;13(2):123-131. doi: 10.1159/000518927. Epub 2021 Nov 4. Mol Syndromol. 2022. PMID: 35418818 Free PMC article.
-
Self-Transcendence of Japanese Female Breast Cancer Patients with Hereditary Breast and Ovarian Cancer Syndrome.Asia Pac J Oncol Nurs. 2021 Oct 4;8(6):670-678. doi: 10.4103/apjon.apjon-218. eCollection 2021 Nov-Dec. Asia Pac J Oncol Nurs. 2021. PMID: 34790851 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous